Ankündigung • Jun 01
Chimcomplex S.A. to Report Q3, 2026 Results on Nov 19, 2026 Chimcomplex S.A. announced that they will report Q3, 2026 results on Nov 19, 2026 Ankündigung • May 17
Chimcomplex S.A. to Report Q1, 2026 Results on May 21, 2026 Chimcomplex S.A. announced that they will report Q1, 2026 results on May 21, 2026 Reported Earnings • May 05
Full year 2025 earnings released: RON0.56 loss per share (vs RON0.009 profit in FY 2024) Full year 2025 results: RON0.56 loss per share (down from RON0.009 profit in FY 2024). Revenue: RON1.04b (down 31% from FY 2024). Net loss: RON171.1m (down RON173.8m from profit in FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 104 percentage points per year, which is a significant difference in performance. Ankündigung • Apr 27
Chimcomplex S.A. to Report Fiscal Year 2025 Results on Apr 27, 2026 Chimcomplex S.A. announced that they will report fiscal year 2025 results on Apr 27, 2026 Ankündigung • Apr 26
Chimcomplex S.A., Annual General Meeting, May 28, 2026 Chimcomplex S.A., Annual General Meeting, May 28, 2026, at 12:00 E. Europe Standard Time. Location: company headquarters located, in onesti municipality, industriilor street, no. 3, bacau county, Romania Reported Earnings • Nov 20
Third quarter 2025 earnings released: RON0.20 loss per share (vs RON0.088 loss in 3Q 2024) Third quarter 2025 results: RON0.20 loss per share (further deteriorated from RON0.088 loss in 3Q 2024). Revenue: RON230.5m (down 29% from 3Q 2024). Net loss: RON60.5m (loss widened 134% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. New Risk • Aug 31
New major risk - Revenue and earnings growth Earnings have declined by 30% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • May 18
First quarter 2025 earnings released First quarter 2025 results: Revenue: RON326.3m (down 24% from 1Q 2024). Net income: RON5.52m (down 26% from 1Q 2024). Profit margin: 1.7% (in line with 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. New Risk • May 02
New major risk - Revenue and earnings growth Earnings have declined by 0.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Ankündigung • Apr 26
Chimcomplex S.A., Annual General Meeting, May 27, 2025 Chimcomplex S.A., Annual General Meeting, May 27, 2025, at 12:00 E. Europe Standard Time. Location: at the company`s headquarters located in onesti, municipality, industriilor street, no. 3, bacau, county, Romania Reported Earnings • Nov 19
Third quarter 2024 earnings released: RON0.088 loss per share (vs RON0.054 loss in 3Q 2023) Third quarter 2024 results: RON0.088 loss per share (further deteriorated from RON0.054 loss in 3Q 2023). Revenue: RON336.0m (up 13% from 3Q 2023). Net loss: RON25.9m (loss widened 58% from 3Q 2023). Reported Earnings • May 19
First quarter 2024 earnings released: EPS: RON0.024 (vs RON0.027 loss in 1Q 2023) First quarter 2024 results: EPS: RON0.024 (up from RON0.027 loss in 1Q 2023). Revenue: RON430.6m (down 1.4% from 1Q 2023). Net income: RON7.44m (up RON15.7m from 1Q 2023). Profit margin: 1.7% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to RON16.95, the stock trades at a trailing P/E ratio of 30.5x. Average trailing P/E is 19x in the Chemicals industry in Europe. Total loss to shareholders of 14% over the past year. New Risk • Mar 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 91% Cash payout ratio: 289% Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to RON16.00, the stock trades at a trailing P/E ratio of 28.8x. Average trailing P/E is 16x in the Chemicals industry in Europe. Total loss to shareholders of 24% over the past year. New Risk • Feb 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 5.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 92% Cash payout ratio: 289% Minor Risks Share price has been volatile over the past 3 months (5.2% average weekly change). Large one-off items impacting financial results. Reported Earnings • Sep 06
Second quarter 2023 earnings released: EPS: RON0.20 (vs RON0.30 in 2Q 2022) Second quarter 2023 results: EPS: RON0.20 (down from RON0.30 in 2Q 2022). Revenue: RON369.8m (down 40% from 2Q 2022). Net income: RON59.7m (down 36% from 2Q 2022). Profit margin: 16% (up from 15% in 2Q 2022). The increase in margin was driven by lower expenses. Upcoming Dividend • Jun 29
Upcoming dividend of RON0.089 per share at 3.5% yield Eligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Payout ratio is on the higher end at 96%, and the cash payout ratio is above 100%. Trailing yield: 3.5%. Lower than top quartile of Romanian dividend payers (8.0%). Lower than average of industry peers (4.2%). New Risk • Jun 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Romanian stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 96% Dividend per share is over 131x cash flows per share. Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Profit margins are more than 30% lower than last year (9.7% net profit margin). Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment improved over the past week After last week's 17% share price gain to RON21.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 13x in the Chemicals industry in Romania. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. No independent directors (4 non-independent directors). Chief Financial Officer and Director Alexa Anisoara was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Buying Opportunity • Oct 15
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 7.0%. The fair value is estimated to be RON22.81, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Earnings per share has grown by 89%. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improved over the past week After last week's 24% share price gain to RON18.80, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 12x in the Chemicals industry in Romania. Upcoming Dividend • Sep 23
Upcoming dividend of RON0.13 per share Eligible shareholders must have bought the stock before 30 September 2022. Payment date: 21 October 2022. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of Romanian dividend payers (8.1%). Lower than average of industry peers (4.2%). Buying Opportunity • Aug 18
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 3.7%. The fair value is estimated to be RON23.54, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 38% over the last 3 years. Earnings per share has grown by 100%. Buying Opportunity • Jul 21
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 2.8%. The fair value is estimated to be RON23.52, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 38% over the last 3 years. Earnings per share has grown by 100%. Buying Opportunity • Jun 27
Now 21% undervalued Over the last 90 days, the stock is up 3.3%. The fair value is estimated to be RON23.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 38% over the last 3 years. Earnings per share has grown by 100%. Buying Opportunity • May 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 16%. The fair value is estimated to be RON23.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 37% over the last 3 years. Earnings per share has grown by 116%. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. No independent directors (4 non-independent directors). Chief Financial Officer and Director Alexa Anisoara was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 34% share price decline to RON14.50, the stock trades at a trailing P/E ratio of 9.5x. Average trailing P/E is 20x in the Chemicals industry in Romania. Reported Earnings • Mar 04
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: RON2.42 (up from RON0.51 in FY 2020). Revenue: RON2.27b (up 90% from FY 2020). Net income: RON464.1m (up 388% from FY 2020). Profit margin: 21% (up from 8.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Board Change • Jan 19
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. Chief Financial Officer and Director Alexa Anisoara was the last director to join the board, commencing their role in 2012. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. 
